Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

$3 million GSK verdict thrown out of court

August 23, 2018 Sales and Marketing GSK, Litigation, antidepressants, suicide, verdict

A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …
News
allergan

FDA refuses Allergan’s uterine bleeding therapy with a request for more data

August 22, 2018 Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma

Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …
News
astrazeneca_sign_sky

Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer

August 21, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma

AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …
News
Image Credit: Bristol-Myers Squibb

FDA approves Bristol Myers Squibb’s Opdivo in small-cell lung cancer

August 20, 2018 Sales and Marketing Bristol-Myers Squibb, FDA, approval, bristol myers squibb, lung cancer, opdivo

The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first …
News
ipos0_l

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018 Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …
News

Thyroid medication recalled after Chinese supplier fails inspection

August 20, 2018 Sales and Marketing China, FDA, recall, thyroid, westminster

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …
News

More children suffering from type 2 diabetes in England and Wales

August 20, 2018 Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …
News

Chinese regulators approve Roche’s Alecensa in regulatory shift

August 20, 2018 Sales and Marketing Cancer, China, Roche, approval, lung cancer

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …
News
andrew_cheng

Gilead CMO announces departure alongside two new exec appointments

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
Appointment
hero-plus

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018 Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …
News
biogen_austria_238

NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay

August 14, 2018 Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy

UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …
News
nawal_ouzren_-_sensorion_alt

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Feature
chris-collins_getty_images

Indicted GOP congressman Chris Collins’ terminates re-election campaign

August 13, 2018 Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma

Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …
News

Astellas acquires gene therapy group Quethera in £85 million deal

August 13, 2018 Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision

The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
News
The Gateway to Local Adoption Series

Latest content

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026

Axplora consolidates liver disease API manufacturing in India

June 23, 2026

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026